This is filed to report endocarditis, and prolonged hospitalization.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 4.On (b)(6) 2020, one clip was successfully deployed, reducing mr to <1.Then on (b)(6) 2021, the patient was readmitted to the hospital with inflammation and pain in the left hip.Transesophageal echocardiogram (tee) was performed and showed vegetation on the mitral valve and on the mitra clip.Staphylococcus epidermidis (skin germ) was detected in the blood culture.The physician stated that it is unknown if the hip infection led to the endocarditis or if the clip caused the infection.The patient was referred to cardiology and was treated with antibiotic therapy.On (b)(6) 2021, the vegetation on the mitral valve declined and the patient was discharged home with oral antibiotic therapy.The clip remains stable on both leaflets, and mr is <1.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the available information, the reported inflammation appears to have been an outcome of the reported endocarditis.A cause for the reported endocarditis could not be determined.The reported patient effect of endocarditis, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.The reported hospitalization or prolonged hospitalization and required medication were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.Na.
|